Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-01

Study Completion Date

2018-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a prospective randomised trial where a computer will randomly allocate

patients to one of two possible methods of delivering oxygen during the procedure of

bronchoscopy. This trial compares high flow nasal cannula (HFNC) with nasal prongs in

delivering oxygen to patients undergoing endo-bronchial ultrasound guided trans-

bronchial nodal aspiration (EBUS-TBNA) a specialised form of bronchoscopy procedure.

HFNC uses humidified higher gas flow rates than conventional low flow systems such as

nasal prongs which are limited by the respiratory rate and effort.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

High - Flow Nasal Cannula Versus Conventional Nasal Cannula During Endobronchial Ultrasound Procedure

NCT06637280

Hypoxemia During EBUS Bronchoscopy

RECRUITING NA

Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

NCT05203328

Lung Cancer

RECRUITING NA

HFNC Versus SOT During EBUS

NCT05425836

Endobronchial Ultrasound

COMPLETED NA

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle

NCT03004586

Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma Lung Cancer

COMPLETED NA

Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA

NCT02813603

Lung Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Lymphadenopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High flow nasal oxygen

(Optiflow; Fisher \& Paykel, Auckland, New Zealand)

Group Type EXPERIMENTAL

high flow nasal oxygen

Intervention Type DEVICE

humidified high flow nasal oxygen

Nasal prongs

Group Type ACTIVE_COMPARATOR

high flow nasal oxygen

Intervention Type DEVICE

humidified high flow nasal oxygen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

high flow nasal oxygen

humidified high flow nasal oxygen

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with a peripheral arterial pulse oximetry ≥ 90% breathing room air
* Age ≥ 18 years
* Able to breathe spontaneously throughout the procedure

Exclusion Criteria

* Respiratory or cardiac failure
* Recent myocardial infarction \< 6 weeks ago
* On long term oxygen therapy, those with tracheostomy and/ or non-invasive or invasive mechanical ventilation
* Nasal and/ or nasopharyngeal disease
* Inability to give informed consent
* Dementia
* Hepatic or end stage renal disease
* Pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No